KelseyCare Advantage’s 4.5-out-of-5-star rating makes it one of the top-rated Medicare Advantage health plans for the greater Houston area by the Centers for Medicare and Medicaid (CMS) for 2025 in the covered counties where KelseyCare Advantage is offered.

CMS measures Medicare Advantage plans on enrollee health outcomes, patient experience, access to in-network care, and other factors.

Since 2008, KelseyCare Advantage has been recognized for delivering top-quality coverage and access to exceptional care. This includes multiple 5-Star ratings by Medicare for quality, service, prescription drug coverage, and member satisfaction.

To learn more about KelseyCare Advantage visit: www.kelseycareadvantage.com

Kelsey-Seybold Clinic has been honored with a Gold Award by the American Heart Association (AHA) for its outstanding participation in the Check. Change. Control. Cholesterol initiative. This national program focuses on improving the identification and management of cholesterol to reduce the risk of heart attacks and strokes. Kelsey-Seybold's recognition with the Gold Award underscores dedication to enhancing heart health and reducing the incidence of heart-related diseases across the nation.

Kelsey-Seybold Clinic has earned the prestigious Gold Plus award from the American Heart Association (AHA) and the American Medical Association (AMA) for its exceptional commitment to controlling high blood pressure through the Target: BP initiative. This national initiative aims to improve blood pressure management, reducing the risk of heart disease and stroke. The Gold Plus award recognizes Kelsey-Seybold’s outstanding efforts in evidence-based care and patient education, contributing to the nationwide fight against hypertension and cardiovascular disease, the leading cause of death in the U.S.

Kelsey-Seybold Clinic has received the prestigious Gold Award from the American Heart Association (AHA) for its outstanding efforts in the Target: Type 2 Diabetes initiative. This program focuses on improving the care and management of individuals with Type 2 diabetes, a major risk factor for cardiovascular disease. The Gold Award recognizes Kelsey-Seybold's commitment to adopting clinical changes and implementing evidence-based strategies and tools to enhance the identification, treatment, and monitoring of Type 2 diabetes. This recognition reflects the clinic's dedication to improving patient outcomes and promoting heart health through continuous innovation and a patient-centered approach.

Kelsey-Seybold Clinic Nuclear Medicine Department maintains accreditation by the Intersocietal Accreditation Commission (IAC). This nationally recognized accreditation highlights Kelsey-Seybold's commitment to providing high-quality, safe, and effective nuclear medicine services. The IAC accreditation process involves a rigorous evaluation of a facility's adherence to national standards and best practices in imaging and patient care. By achieving this distinction, Kelsey-Seybold demonstrates its dedication to excellence in diagnostic imaging, ensuring that patients receive the highest standard of care in nuclear medicine. This recognition underscores the clinic's ongoing focus on advanced, evidence-based practices for accurate diagnosis and improved patient outcomes.

Kelsey-Seybold Clinic has earned accreditation from the Intersocietal Accreditation Commission (IAC) for its echocardiography services. This prestigious recognition affirms the clinic’s commitment to providing high-quality, reliable, and patient-centered cardiac imaging. The IAC’s accreditation process involves a comprehensive review of a facility’s adherence to strict standards in both technical performance and patient care. By achieving this accreditation, Kelsey-Seybold demonstrates its dedication to excellence in diagnostic cardiology, ensuring that patients receive accurate and timely assessments of heart function.